Cargando…
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) global pandemic. The first step of viral infection is cell attachment, which is mediated by the binding of the SARS-CoV-2 receptor binding domain (RBD), part of the virus spike pro...
Autores principales: | David, Alon Ben, Diamant, Eran, Dor, Eyal, Barnea, Ada, Natan, Niva, Levin, Lilach, Chapman, Shira, Mimran, Lilach Cherry, Epstein, Eyal, Zichel, Ran, Torgeman, Amram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198929/ https://www.ncbi.nlm.nih.gov/pubmed/34072087 http://dx.doi.org/10.3390/molecules26113213 |
Ejemplares similares
-
Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021) -
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
por: Mechaly, Adva, et al.
Publicado: (2022) -
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations
por: Torgeman, Amram, et al.
Publicado: (2017) -
A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism
por: Torgeman, Amram, et al.
Publicado: (2021) -
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
por: Diamant, Eran, et al.
Publicado: (2015)